<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.3//EN" "ep-patent-document-v1-3.dtd">
<ep-patent-document id="EP03784567B8W1" file="EP03784567W1B8.xml" lang="en" country="EP" doc-number="1527049" kind="B8" correction-code="W1" date-publ="20081029" status="c" dtd-version="ep-patent-document-v1-3">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHU..SK................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>1527049</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20081029</date></B140><B150><B151>W1</B151><B153>30 54</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>03784567.4</B210><B220><date>20030807</date></B220><B240><B241><date>20050216</date></B241><B242><date>20060518</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>2002231950</B310><B320><date>20020808</date></B320><B330><ctry>JP</ctry></B330><B310>2003051575</B310><B320><date>20030227</date></B320><B330><ctry>JP</ctry></B330></B300><B400><B405><date>20081029</date><bnum>200844</bnum></B405><B430><date>20050504</date><bnum>200518</bnum></B430><B450><date>20080716</date><bnum>200829</bnum></B450><B452EP><date>20080129</date></B452EP><B480><date>20081029</date><bnum>200844</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07D 215/18        20060101AFI20050224BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>KONDENSIERTE HETEROZYKLISCHE VERBINDUNGEN ALS PETIDASE INHIBITOREN</B542><B541>en</B541><B542>FUSED HETEROCYCLIC COMPOUNDS AS PEPTIDASE INHIBITORS</B542><B541>fr</B541><B542>COMPOSES HETEROCYCLIQUES FUSIONNES EN TANT QU'INHIBITEURS DE PEPTIDASE</B542></B540><B560><B561><text>WO-A-98/19998</text></B561><B561><text>WO-A-03/068748</text></B561><B562><text>AUGUSTYNS K ET AL: "THE UNIQUE PROPERTIES OF DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26) AND THE THERAPEUTIC POTENTIAL OF DPP IV INHIBITORS" CURRENT MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS BV, BE, vol. 6, no. 4, 1999, pages 311-327, XP000870290 ISSN: 0929-8673</text></B562></B560></B500><B700><B720><B721><snm>OI, Satoru</snm><adr><str>7-10-509, Ayameikeminami 1-chome</str><city>Nara-shi, Nara 631-0033</city><ctry>JP</ctry></adr></B721><B721><snm>MAEZAKI, Hironobu</snm><adr><str>6-7-206, Honmachi 5-chome</str><city>Toyonaka-shi, Osaka 560-0021</city><ctry>JP</ctry></adr></B721><B721><snm>IKEDOU, Koji</snm><adr><str>6-4, Besshochokobayashi</str><city>Himeji-shi, Hyogo 671-0222</city><ctry>JP</ctry></adr></B721></B720><B730><B731><snm>Takeda Pharmaceutical Company Limited</snm><iid>04984112</iid><irf>GW/G25557EP</irf><adr><str>1-1, Doshomachi 4-chome 
Chuo-ku</str><city>Osaka-shi,
Osaka 541-0045</city><ctry>JP</ctry></adr></B731></B730><B740><B741><snm>Wright, Robert Gordon McRae</snm><iid>00055363</iid><adr><str>Elkington and Fife LLP, 
Prospect House, 
8 Pembroke Road</str><city>Sevenoaks,
Kent TN13 1XR</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>JP2003010054</anum></dnum><date>20030807</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2004014860</pnum></dnum><date>20040219</date><bnum>200408</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
